Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-017212
Filing Date
2025-06-30
Accepted
2025-06-30 17:28:36
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 2758379
2 EX-19.1 ex19-1.htm EX-19.1 93310
3 EX-21.1 ex21-1.htm EX-21.1 2158
4 EX-23.1 ex23-1.htm EX-23.1 4143
5 EX-23.2 ex23-2.htm EX-23.2 5138
6 EX-31.1 ex31-1.htm EX-31.1 17650
7 EX-31.2 ex31-2.htm EX-31.2 17654
8 EX-32.1 ex32-1.htm EX-32.1 7267
9 GRAPHIC form10-k_001.jpg GRAPHIC 7273
  Complete submission text file 0001641172-25-017212.txt   12011419

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE qlgn-20241231.xsd EX-101.SCH 93527
11 XBRL CALCULATION FILE qlgn-20241231_cal.xml EX-101.CAL 90995
12 XBRL DEFINITION FILE qlgn-20241231_def.xml EX-101.DEF 401330
13 XBRL LABEL FILE qlgn-20241231_lab.xml EX-101.LAB 731556
14 XBRL PRESENTATION FILE qlgn-20241231_pre.xml EX-101.PRE 574716
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2015473
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 251093391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)